Zynerba Pharmaceuticals Closes Initial Public Offering

Zynerba Pharmaceuticals (NASDAQ:ZYNE) announced the closing of its initial public offering of 3.45 million shares of common stock at a price of $14 per share, before underwriting discounts.
As quoted in the press release:

Zynerba Pharmaceuticals, Inc. announced today the closing of its initial public offering of 3,450,000 shares of common stock at a public offering price of $14.00 per share, before underwriting discounts, which includes the exercise in full by the underwriters of their option to purchase up to 450,000 additional shares of common stock at the public offering price, resulting in gross proceeds of $48.3 million. All of the shares in the offering were sold by Zynerba.

Click here to read the full Zynerba Pharmaceuticals (NASDAQ:ZYNE) press release.